octane has been researched along with beta-lactams in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biondi, S; Long, S; Panunzio, M; Qin, WL | 1 |
Bajaksouzian, S; Barnes, MD; Bethel, CR; Bhagwat, SS; Bhavsar, S; Bonomo, RA; Deshpande, PK; Jacobs, MR; Kumar, V; Nguyen, NQ; Papp-Wallace, KM; Patel, MV; Patil, V; Rather, PN; Ravikumar, T; Rudin, SD; van den Akker, F; Yeole, R | 1 |
1 review(s) available for octane and beta-lactams
Article | Year |
---|---|
Current trends in β-lactam based β-lactamases inhibitors.
Topics: Animals; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Humans; Octanes | 2011 |
1 other study(ies) available for octane and beta-lactams
Article | Year |
---|---|
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234.
Topics: Animals; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Bridged Bicyclo Compounds; Cyclooctanes; Drug Synergism; Gram-Negative Bacteria; Lung; Mice; Octanes; Peritonitis; Piperidines | 2018 |